| Accession Number | 0002040805-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 21, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Purchase | 35,000 | $0.81 | $28,430.50 | 83,178 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Feb 12, 2026 | Grant/Award | 205,000 | $0.00 | $0.00 | 205,000 | Direct | โ | View Details |